These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18083789)

  • 1. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2008 Apr; 31(4):714-9. PubMed ID: 18083789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2007 Feb; 30(2):292-9. PubMed ID: 17259497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetologia; 2006 Jan; 49(1):56-65. PubMed ID: 16365726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis.
    Vazquez-Benitez G; Desai JR; Xu S; Goodrich GK; Schroeder EB; Nichols GA; Segal J; Butler MG; Karter AJ; Steiner JF; Newton KM; Morales LS; Pathak RD; Thomas A; Reynolds K; Kirchner HL; Waitzfelder B; Elston Lafata J; Adibhatla R; Xu Z; O'Connor PJ
    Diabetes Care; 2015 May; 38(5):905-12. PubMed ID: 25710922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial.
    Branch M; German C; Bertoni A; Yeboah J
    J Diabetes Complications; 2019 Jul; 33(7):468-472. PubMed ID: 31088728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey.
    Gregg EW; Cheng YJ; Saydah S; Cowie C; Garfield S; Geiss L; Barker L
    Diabetes Care; 2012 Jun; 35(6):1252-7. PubMed ID: 22619288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
    Niskanen L; Turpeinen A; Penttilä I; Uusitupa MI
    Diabetes Care; 1998 Nov; 21(11):1861-9. PubMed ID: 9802734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and number of years of life lost with and without cardiovascular disease: a multi-state homogeneous semi-Markov model.
    Ramezankhani A; Azizi F; Hadaegh F; Momenan AA
    Acta Diabetol; 2018 Mar; 55(3):253-262. PubMed ID: 29299678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study.
    Ong G; Davis TM; Davis WA
    Diabetes Care; 2010 Feb; 33(2):317-21. PubMed ID: 19918016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2005 Dec; 28(12):2901-7. PubMed ID: 16306552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
    Wei M; Gaskill SP; Haffner SM; Stern MP
    Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.
    Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS
    J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
    Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
    Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
    Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
    Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Fornengo P; Novelli G; Panero F; Perotto M; Segre O; Zucco C; Deambrogio P; Bargero G; Perin PC
    Diabetes; 2009 Apr; 58(4):926-33. PubMed ID: 19074985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J; Forsblom C; Thorn LM; Gordin D; Saraheimo M; Groop PH;
    Diabetes; 2009 Nov; 58(11):2649-55. PubMed ID: 19651819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study.
    Schoenaker DA; Toeller M; Chaturvedi N; Fuller JH; Soedamah-Muthu SS;
    Diabetologia; 2012 Aug; 55(8):2132-41. PubMed ID: 22526612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes.
    Bidel S; Hu G; Qiao Q; Jousilahti P; Antikainen R; Tuomilehto J
    Diabetologia; 2006 Nov; 49(11):2618-26. PubMed ID: 17019600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.